| Dr Stephen Eugene Warren Ix, OD | |
|
305 Alabama Ave, Bogalusa, LA 70427-3805 | |
| (985) 732-5181 | |
| Not Available |
| Full Name | Dr Stephen Eugene Warren Ix |
|---|---|
| Gender | Male |
| Speciality | Optometrist |
| Location | 305 Alabama Ave, Bogalusa, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659471340 | NPI | - | NPPES |
| 1139050 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 756-192T (Louisiana) | Primary |
| Provider Name | Stephen E. Warren Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1427174010 PECOS PAC ID: 2769679257 Enrollment ID: O20101209000718 |
News Archive
AstraZeneca announced today that the US Food and Drug Administration (FDA) has issued a complete response letter (CRL) for the New Drug Application (NDA) for ticagrelor (BRILINTA™).
Building upon earlier research, investigators at UT Southwestern Medical Center and their collaborators have identified a new innate immunity pathway that protects mammals from viral oncogenesis, the process by which viruses cause normal cells to become cancerous.
The National Heart, Lung and Blood Institute of the National Institutes of Health has awarded a five-year grant of $15.6 million to Karina Yazdanbakhsh, PhD, of New York Blood Center's Lindsley F. Kimball Research Institute, to lead a collaborative research program studying the consequences of transfusions in patients with sickle cell disease and developing strategies to optimize transfusion management for this patient group.
The U.S. Food and Drug Administration has approved the pediatric use of Protopam Chloride (pralidoxime chloride), a drug used to treat poisoning by organophosphate pesticides and chemicals (e.g., nerve agents). The drug is approved to be administered either by intravenous (IV) or intramuscular (IM) injections.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Stephen Eugene Warren Ix, OD 305 Alabama Ave, Bogalusa, LA 70427-3805 Ph: (985) 732-5181 | Dr Stephen Eugene Warren Ix, OD 305 Alabama Ave, Bogalusa, LA 70427-3805 Ph: (985) 732-5181 |
News Archive
AstraZeneca announced today that the US Food and Drug Administration (FDA) has issued a complete response letter (CRL) for the New Drug Application (NDA) for ticagrelor (BRILINTA™).
Building upon earlier research, investigators at UT Southwestern Medical Center and their collaborators have identified a new innate immunity pathway that protects mammals from viral oncogenesis, the process by which viruses cause normal cells to become cancerous.
The National Heart, Lung and Blood Institute of the National Institutes of Health has awarded a five-year grant of $15.6 million to Karina Yazdanbakhsh, PhD, of New York Blood Center's Lindsley F. Kimball Research Institute, to lead a collaborative research program studying the consequences of transfusions in patients with sickle cell disease and developing strategies to optimize transfusion management for this patient group.
The U.S. Food and Drug Administration has approved the pediatric use of Protopam Chloride (pralidoxime chloride), a drug used to treat poisoning by organophosphate pesticides and chemicals (e.g., nerve agents). The drug is approved to be administered either by intravenous (IV) or intramuscular (IM) injections.
› Verified 6 days ago
Marc Hautot, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 409 Avenue F, Bogalusa, LA 70427 Phone: 985-735-8137 Fax: 985-732-4777 | |
Can, Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 413 Austin St, Bogalusa, LA 70427 Phone: 985-732-4900 |